![PDF) Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small–Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01) PDF) Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small–Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01)](https://i1.rgstatic.net/publication/338180496_Potential_Antiangiogenic_Treatment_Eligibility_of_Patients_with_Squamous_Non-Small-Cell_Lung_Cancer_EPISQUAMAB_Study_GFPC_2015-01/links/5e05555492851c83649ddb27/largepreview.png)
PDF) Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small–Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01)
Management of Cancerâ•'Related Anemia in Patients with Breast or Gynecologic Cancer: New Insights Based on Results from the
![Severe maternal morbidity by mode of delivery in women with twin pregnancy and planned vaginal delivery | Scientific Reports Severe maternal morbidity by mode of delivery in women with twin pregnancy and planned vaginal delivery | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-61720-w/MediaObjects/41598_2020_61720_Fig1_HTML.png)
Severe maternal morbidity by mode of delivery in women with twin pregnancy and planned vaginal delivery | Scientific Reports
![Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema | Scientific Reports Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-22838-1/MediaObjects/41598_2022_22838_Fig2_HTML.png)
Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema | Scientific Reports
![PDF) Is Intrapartum Intravenous Zidovudine for Prevention of Mother-to-Child HIV-1 Transmission Still Useful in the Combination Antiretroviral Therapy Era? | Didier Pinquier - Academia.edu PDF) Is Intrapartum Intravenous Zidovudine for Prevention of Mother-to-Child HIV-1 Transmission Still Useful in the Combination Antiretroviral Therapy Era? | Didier Pinquier - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/81552273/mini_magick20220301-16351-1535e8.png?1646203416)
PDF) Is Intrapartum Intravenous Zidovudine for Prevention of Mother-to-Child HIV-1 Transmission Still Useful in the Combination Antiretroviral Therapy Era? | Didier Pinquier - Academia.edu
![Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis - Phan - 2019 - Journal of the European Academy of Dermatology Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis - Phan - 2019 - Journal of the European Academy of Dermatology](https://onlinelibrary.wiley.com/cms/asset/401ce667-6a17-479d-999e-1860e0c2be1a/jdv15579-fig-0002-m.jpg)
Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis - Phan - 2019 - Journal of the European Academy of Dermatology
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline - Clinical Nutrition
Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000 | PLOS ONE
![Lorlatinib for advanced anaplastic lymphoma kinase–positive non–small cell lung cancer: Results of the IFCT-1803 LORLATU cohort - European Journal of Cancer Lorlatinib for advanced anaplastic lymphoma kinase–positive non–small cell lung cancer: Results of the IFCT-1803 LORLATU cohort - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5116e09d-67cc-40a7-a58d-da0043fe2e34/gr2_lrg.jpg)
Lorlatinib for advanced anaplastic lymphoma kinase–positive non–small cell lung cancer: Results of the IFCT-1803 LORLATU cohort - European Journal of Cancer
![Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation - Lung Cancer Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/431739b8-f701-4273-83c5-f357e1dd2d4f/gr1_lrg.jpg)